{"title":"Novel approaches to prevent or cure allergic diseases","authors":"Serena Zadoo , Carla McGuire Davis","doi":"10.1016/j.coi.2025.102569","DOIUrl":null,"url":null,"abstract":"<div><div>Prevention remains a critical goal to improve quality of life, given the chronic nature of allergic conditions and the interplay between them contributing to the atopic march. In this review, we will highlight key novel approaches to preventing allergic disease using a top-down approach (primary to secondary to tertiary). Significant advancements in the field have resulted in cutting-edge therapies and options for patients to optimize their health and quality of life. These include early introduction of allergenic foods; oral, sublingual, epicutaneous, and subcutaneous immunotherapy; biologic therapy; and elimination of allergen or irritant skin exposures. Further research and developments are necessary to prevent the atopic march and continue the progression of diagnostic and treatment modalities in allergic diseases.</div></div>","PeriodicalId":11361,"journal":{"name":"Current Opinion in Immunology","volume":"95 ","pages":"Article 102569"},"PeriodicalIF":5.8000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0952791525000457","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Prevention remains a critical goal to improve quality of life, given the chronic nature of allergic conditions and the interplay between them contributing to the atopic march. In this review, we will highlight key novel approaches to preventing allergic disease using a top-down approach (primary to secondary to tertiary). Significant advancements in the field have resulted in cutting-edge therapies and options for patients to optimize their health and quality of life. These include early introduction of allergenic foods; oral, sublingual, epicutaneous, and subcutaneous immunotherapy; biologic therapy; and elimination of allergen or irritant skin exposures. Further research and developments are necessary to prevent the atopic march and continue the progression of diagnostic and treatment modalities in allergic diseases.
期刊介绍:
Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.
In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.
Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.
Current Opinion in Immunology builds on Elsevier''s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists'' workflow.